Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 62 M60 M58 M59 M62 M 239 M Research & development ————— — Operating income 431 M727 M356 M746 M679 M 2.51 B Non-Operating Income, Total -14 M-6 M-32 M18 M-6 M -26 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 25 M18 M17 M34 M22 M 91 M Unusual income/expense -39 M-24 M-49 M-16 M-28 M -117 M Pretax income 306 M611 M219 M635 M569 M 2.03 B Equity in earnings ————— — Taxes 103 M131 M199 M46 M105 M 481 M Non-controlling/minority interest -1 M8 M2 M03 M 13 M After tax other income/expense 305 M122 M-2 M127 M234 M 481 M Net income before discontinued operations 204 M472 M18 M589 M461 M 1.54 B Discontinued operations ————— — Net income 204 M472 M18 M589 M461 M 1.54 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 204 M472 M18 M589 M461 M 1.54 B Basic earnings per share (Basic EPS) 0.240.550.02—0.55 — Diluted earnings per share (Diluted EPS) 0.240.550.020.690.55 1.81 Average basic shares outstanding 866 M857 M849 M853 M837 M — Diluted shares outstanding 866 M857 M850 M853 M839 M — EBITDA 708 M1.01 B641 M1.04 B974 M 3.66 B EBIT 431 M727 M356 M746 M679 M 2.51 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 277 M284 M285 M290 M295 M 1.15 B